Skip to main content

Advertisement

SpringerLink
Log in

Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the safety and efficiency of microwave ablation (MWA) with low power of 20 w, respectively, in the treatment of cervical metastatic lymph node (CMLN) from papillary thyroid carcinoma (PTC) with a mean of 32-month follow-up.

Methods

Eleven patients in total with 24 cervical lymph nodes (LNs) diagnosed with CMLN from PTC underwent MWA at a power of 20 w. We recorded images of the LNs under ultrasound first before MWA and 1, 3, 6, 12, months after MWA, and then every 6 months, respectively. The volumes of the LNs were compared before MWA and at each follow-up point after MWA. The thyroglobulin (Tg) test was performed before MWA and 3 months after MWA.

Results

All patients were successfully treated, and they showed no major complications. Before MWA, the mean volume of the LNs was 364.15 ± 306.89 mm3, which decreased to 234.10 ± 230.34 mm3, 107.51 ± 129.47 mm3, 20.88 ± 39.27 mm3, 3.38 ± 12.74 mm3, and completely disappeared at the follow-up point of 1, 3, 6, 12, and 18 months after MWA, respectively. The mean Tg was 11.81 ± 7.50 ng/ml, a data significantly decreased to 0.43 ± 0.11 ng/ml 3 months after MWA (P = 0.000). In the follow-up period, no recurrent lesions were found.

Conclusions

For the treatment of CMLN from PTC, low power MWA showed good safety and efficacy. MWA is likely to be a candidate for patients with high risks or who refuse reoperation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2018. CA Cancer J. Clin. 68(1), 7–30 (2018). https://doi.org/10.3322/caac.21442

    Article  PubMed  Google Scholar 

  2. L.G. Morris, R.M. Tuttle, L. Davies, Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol. Head. Neck Surg. 142(7), 709–711 (2016). https://doi.org/10.1001/jamaoto.2016.0230

    Article  PubMed  PubMed Central  Google Scholar 

  3. N.A. Johnson, M.E. Tublin, Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology 249(2), 429–444 (2008). https://doi.org/10.1148/radiol.2492071313. 6.798

    Article  PubMed  Google Scholar 

  4. K.D. Burman, Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J. Clin. Endocrinol. Metab. 97(8), 2623–2625 (2012). https://doi.org/10.1210/jc.2012-2480

    Article  CAS  PubMed  Google Scholar 

  5. I.D. Hay, G.B. Thompson, C.S. Grant, E.J. Bergstralh, C.E. Dvorak, C.A. Gorman, M.S. Maurer, B. McIver, B.P. Mullan, A.L. Oberg, C.C. Powell, J.A. van Heerden, J.R. Goellner, Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J. Surg. 26(8), 879–885 (2002). https://doi.org/10.1007/s00268-002-6612-1. 2.523

    Article  PubMed  Google Scholar 

  6. P. Liang, Y. Wang, X. Yu, B. Dong, Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 251(3), 933–940 (2009). https://doi.org/10.1148/radiol.2513081740

    Article  PubMed  Google Scholar 

  7. J. Yu, P. Liang, X.L. Yu, Z.G. Cheng, Z.Y. Han, X. Zhang, J. Dong, M.J. Mu, X. Li, X.H. Wang, US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology 270(3), 880–887 (2014). https://doi.org/10.1148/radiol.13130275

    Article  PubMed  Google Scholar 

  8. M. Li, X. Yu, P. Liang, B. Dong, F. Liu, Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J. Hyperth. 31(6), 579–587 (2015). https://doi.org/10.3109/02656736.2015.1014869

    Article  Google Scholar 

  9. L. Sidoff, D.E. Dupuy, Clinical experiences with microwave thermal ablation of lung malignancies. Int. J. Hyperth. 33(1), 25–33 (2017). https://doi.org/10.1080/02656736.2016.1204630

    Article  CAS  Google Scholar 

  10. Y. Korkusuz, O.M. Mader, W. Kromen, C. Happel, S. Ahmad, D. Groner, M. Koca, A. Mader, F. Grunwald, H. Korkusuz, Cooled microwave ablation of thyroid nodules: Initial experience. Eur. J. Radiol. 85(11), 2127–2132 (2016). https://doi.org/10.1016/j.ejrad.2016.09.019

    Article  PubMed  Google Scholar 

  11. W. Yue, S. Wang, S. Yu, B. Wang, Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J. Hyperth. 30(2), 150–157 (2014). https://doi.org/10.3109/02656736.2014.885590

    Article  Google Scholar 

  12. D. Teng, G. Sui, C. Liu, Y. Wang, Y. Xia, H. Wang, Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J. Cancer Res. Clin. Oncol. (2018). https://doi.org/10.1007/s00432-018-2607-7

    Article  PubMed  Google Scholar 

  13. W. Yue, L. Chen, S. Wang, S. Yu, Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: A prospective study. Int J. Hyperth. 31(4), 403–408 (2015). https://doi.org/10.3109/02656736.2015.1014433

    Article  Google Scholar 

  14. W.K. Jeong, J.H. Baek, H. Rhim, Y.S. Kim, M.S. Kwak, H.J. Jeong, D. Lee, Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur. Radiol. 18(6), 1244–1250 (2008). https://doi.org/10.1007/s00330-008-0880-6

    Article  PubMed  Google Scholar 

  15. J.E. Shin, J.H. Baek, J.H. Lee, Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr. Opin. Oncol. 25(1), 14–19 (2013). https://doi.org/10.1097/CCO.0b013e32835a583d. 4.614

    Article  CAS  PubMed  Google Scholar 

  16. B.D. Lewis, I.D. Hay, J.W. Charboneau, B. McIver, C.C. Reading, J.R. Goellner, Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am. J. Roentgenol. 178(3), 699–704 (2002). https://doi.org/10.2214/ajr.178.3.1780699

    Article  CAS  PubMed  Google Scholar 

  17. A. Heilo, E. Sigstad, K.H. Fagerlid, O.I. Haskjold, K.K. Groholt, A. Berner, T. Bjoro, L.H. Jorgensen, Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 96(9), 2750–2755 (2011). https://doi.org/10.1210/jc.2010-2952

    Article  CAS  PubMed  Google Scholar 

  18. J.P. Guenette, J.M. Monchik, D.E. Dupuy, Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J. Vasc. Interv. Radiol. 24(5), 672–679 (2013). https://doi.org/10.1016/j.jvir.2013.02.001. 2.57

    Article  PubMed  Google Scholar 

  19. I.D. Hay, R.A. Lee, C. Davidge-Pitts, C.C. Reading, J.W. Charboneau, Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery 154(6), 1448–1454 (2013). https://doi.org/10.1016/j.surg.2013.07.007

    Article  PubMed  Google Scholar 

  20. T.E. Fontenot, A. Deniwar, P. Bhatia, Z. Al-Qurayshi, G.W. Randolph, E. Kandil, Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer: a systematic review and pooled analysis. JAMA Otolaryngol. Head Neck Surg. 141(6), 512–518 (2015). https://doi.org/10.1001/jamaoto.2015.0596

    Article  PubMed  Google Scholar 

  21. D.E. Dupuy, J.M. Monchik, C. Decrea, L. Pisharodi, Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130(6), 971–977 (2001). https://doi.org/10.1067/msy.2001.118708. 3.309

    Article  CAS  PubMed  Google Scholar 

  22. J.M. Monchik, G. Donatini, J. Iannuccilli, D.E. Dupuy, Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. ANN SURG 244(2), 296–304 (2006). https://doi.org/10.1097/01.sla.0000217685.85467.2d. 8.569

    Article  PubMed  PubMed Central  Google Scholar 

  23. J.H. Baek, Y.S. Kim, J.Y. Sung, H. Choi, J.H. Lee, Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am. J. Roentgenol. 197(2), W331–336 (2011). https://doi.org/10.2214/ajr.10.5345

    Article  PubMed  Google Scholar 

  24. K.W. Park, J.H. Shin, B.K. Han, E.Y. Ko, J.H. Chung, Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann. Surg. Oncol. 18(9), 2564–2568 (2011). https://doi.org/10.1245/s10434-011-1619-1. 3.655

    Article  PubMed  Google Scholar 

  25. J.H. Kim, W.S. Yoo, Y.J. Park, D.J. Park, T.J. Yun, S.H. Choi, C.H. Sohn, K.E. Lee, M.W. Sung, Y.K. Youn, K.H. Kim, B.Y. Cho, Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276(3), 909–918 (2015). https://doi.org/10.1148/radiol.15140079. 6.798

    Article  PubMed  Google Scholar 

  26. H.K. Lim, J.H. Baek, J.H. Lee, W.B. Kim, T.Y. Kim, Y.K. Shong, S.J. Hong, Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur. Radiol. 25(1), 163–170 (2015). https://doi.org/10.1007/s00330-014-3405-5. 3.64

    Article  PubMed  Google Scholar 

  27. Y. Guang, Y. Luo, Y. Zhang, M. Zhang, N. Li, Y. Zhang, J. Tang, Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J. Cancer Res. Clin. Oncol. 143(8), 1555–1562 (2017). https://doi.org/10.1007/s00432-017-2386-6

    Article  CAS  PubMed  Google Scholar 

  28. G. Mauri, L. Cova, T. Tondolo, T. Ierace, A. Baroli, E. Di Mauro, C.M. Pacella, S.N. Goldberg, L. Solbiati, Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J. Clin. Endocrinol. Metab. 98(7), E1203–1207 (2013). https://doi.org/10.1210/jc.2013-1140

    Article  CAS  PubMed  Google Scholar 

  29. E. Papini, G. Bizzarri, A. Bianchini, D. Valle, I. Misischi, R. Guglielmi, M. Salvatori, L. Solbiati, A. Crescenzi, C.M. Pacella, H. Gharib, Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 98(1), E92–97 (2013). https://doi.org/10.1210/jc.2012-2991

    Article  CAS  PubMed  Google Scholar 

  30. G. Mauri, L. Cova, T. Ierace, A. Baroli, E. Di Mauro, C.M. Pacella, S.N. Goldberg, L. Solbiati, Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc. Interv. Radiol. 39(7), 1023–1030 (2016). https://doi.org/10.1007/s00270-016-1313-6

    Article  Google Scholar 

  31. W. Zhou, L. Zhang, W. Zhan, S. Jiang, Y. Zhu, S. Xu, Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma<15 mm. Clin. Radiol. 71(12), 1233–1239 (2016). https://doi.org/10.1016/j.crad.2016.07.010. 2.151

    Article  CAS  PubMed  Google Scholar 

  32. B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020. 3.784

    Article  PubMed  PubMed Central  Google Scholar 

  33. N. Bhardwaj, A.D. Strickland, F. Ahmad, L. Atanesyan, K. West, D.M. Lloyd, A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology 41(2), 168–172 (2009). https://doi.org/10.1080/00313020802579292. 2.968

    Article  CAS  PubMed  Google Scholar 

  34. W. Shady, E.N. Petre, K.G. Do, M. Gonen, H. Yarmohammadi, K.T. Brown, N.E. Kemeny, M. D’Angelica, P.T. Kingham, S.B. Solomon, C.T. Sofocleous, Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J. Vasc. Interv. Radiol. 29(2), 268–275.e261 (2018). https://doi.org/10.1016/j.jvir.2017.08.021. 2.57

    Article  PubMed  Google Scholar 

  35. B. Feng, P. Liang, Z. Cheng, X. Yu, J. Yu, Z. Han, F. Liu, Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur. J. Endocrinol. 166(6), 1031–1037 (2012). https://doi.org/10.1530/EJE-11-0966

    Article  CAS  PubMed  Google Scholar 

  36. B. Wang, Z.Y. Han, J. Yu, Z. Cheng, F. Liu, X.L. Yu, C. Chen, J. Liu, P. Liang, Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation. Int. J. Hyperthermia 33(4), 459–464 (2017). https://doi.org/10.1080/02656736.2016.1274058

    Article  PubMed  Google Scholar 

  37. H. Korkusuz, C. Happel, D.A. Koch, F. Gruenwald, Combination of ultrasound-guided percutaneous microwave ablation and radioiodine therapy in benign thyroid disease: A 3-month follow-up study. Rofo 188(1), 60–68 (2016). https://doi.org/10.1055/s-0041-106538

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by the Finance Department of Jilin Province (No.SCZSY201701) and the Jilin Provincial Health and Family Planning Commission (NO.2016ZC032).

Author information

Authors and Affiliations

  1. Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130000, China

    Dengke Teng & Hui Wang

  2. Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130000, China

    Lei Ding

  3. Department of Interventional Ultrasound, the 208th Hospital of PLA, Changchun, Jilin, 130000, China

    Yu Wang, Caimei Liu & Yongxu Xia

Authors
  1. Dengke Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Caimei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongxu Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teng, D., Ding, L., Wang, Y. et al. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study. Endocrine 62, 648–654 (2018). https://doi.org/10.1007/s12020-018-1711-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1711-4

Keywords

Search

Navigation